Colorectal cancer liver metastases: Genomics and biomarkers with focus on local therapies
Y Kitsel, T Cooke, V Sotirchos, CT Sofocleous - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer (CRC) is a leading cause of death among cancer
patients, and the liver is the most common visceral metastatic site. Despite promising …
patients, and the liver is the most common visceral metastatic site. Despite promising …
[HTML][HTML] Colorectal cancer liver metastasis: evolving paradigms and future directions
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key
goals for improving outcomes including early detection, effective prognostic indicators of …
goals for improving outcomes including early detection, effective prognostic indicators of …
The role of biomarkers in the management of colorectal liver metastases
Simple Summary Colorectal cancer remains one of the most significant sources of cancer-
related morbidity and mortality worldwide. The liver is the most common site of metastatic …
related morbidity and mortality worldwide. The liver is the most common site of metastatic …
Tailored systemic therapy for colorectal cancer liver metastases
C Czauderna, K Luley, N von Bubnoff… - International Journal of …, 2021 - mdpi.com
Liver metastases are the most common site of metastatic spread in colorectal cancer.
Current treatment approaches involve effective systemic therapies in combination with …
Current treatment approaches involve effective systemic therapies in combination with …
Proteomic profiling and biomarker discovery in colorectal liver metastases
Colorectal liver metastases (CRLM) are the leading cause of death among patients with
metastatic colorectal cancer (CRC). As part of multimodal therapy, liver resection is the …
metastatic colorectal cancer (CRC). As part of multimodal therapy, liver resection is the …
Emerging paradigms in the treatment of liver metastases in colorectal cancer
A Alhumaid, Z AlYousef, HA Bakhsh… - Critical Reviews in …, 2018 - Elsevier
Efforts to combat colorectal cancer have benefited from improved screening and
surveillance, which facilitates early detection. The survival rate associated with diagnosis at …
surveillance, which facilitates early detection. The survival rate associated with diagnosis at …
Colorectal liver metastases: does the future of precision medicine lie in genetic testing?
Colorectal liver metastases (CRLM) present an important clinical challenge in both surgical
and medical oncology. Despite improvements in management, survival among patients …
and medical oncology. Despite improvements in management, survival among patients …
[HTML][HTML] Is there a genetic signature for liver metastasis in colorectal cancer?
C Nadal, J Maurel, P Gascon - World journal of gastroenterology …, 2007 - ncbi.nlm.nih.gov
Even though liver metastasis accounts for the vast majority of cancer deaths in patients with
colorectal cancer (CRC), fundamental questions about the molecular and cellular …
colorectal cancer (CRC), fundamental questions about the molecular and cellular …
Integrated Clinical-Molecular classification of Colorectal Liver metastases: a biomarker analysis of the phase 3 New EPOC Randomized Clinical Trial
RR Katipally, CA Martinez, SA Pugh… - JAMA …, 2023 - jamanetwork.com
Importance Personalized treatment approaches for patients with oligometastatic colorectal
liver metastases are critically needed. We previously defined 3 biologically distinct …
liver metastases are critically needed. We previously defined 3 biologically distinct …
Personalized treatment in patients with colorectal liver metastases
Abstract Background Precision Medicine Initiative is a new research effort aiming to offer
personalized treatment in many diseases, including cancer. The aim of the present article is …
personalized treatment in many diseases, including cancer. The aim of the present article is …
相关搜索
- genomics and biomarkers local therapies
- colorectal cancer liver metastases
- biomarkers in the management liver metastases
- colorectal cancer genetic signature
- personalized treatment liver metastases
- proteomic profiling liver metastases
- genetic testing liver metastases
- precision medicine liver metastases
- biomarker analysis liver metastases
- biomarker discovery liver metastases
- colorectal carcinoma liver metastases